<p>Seminal vesicles and Prostate gland S-IV RM25</p><p> Learninig Objectives </p><p> At the end of the lecture student will able :</p><p> To define the seminal vesicles and prostate of male reproductive system.</p><p> Explain the relation and anatomical position of these gland.</p><p> Discuss the clinical associations of these gland </p><p> Seminal vesicles</p><p> Thin walled lobulated sacs situated b/w bladder & rectum.</p><p> Each vesicle is about 5 cm long. Applied base of bladder above prostate.</p><p> Directed upwards & laterally.</p><p> Produce 60% of seminal fluid.</p><p> Their tops are just covered by peritoneum of rectovesical pouch.</p><p> Rectovesical fascia lies behind them.</p><p> Each lies lateral to ampulla of the ductus deferens of its own side.</p><p> At lower end of ampulla behind prostate the duct of seminal vesicle join ductus to form ejaculatory ductus.</p><p> Arterial supply of seminal vesicle </p><p> Supplied by branches from.</p><p>› Inferior vesical arteries. </p><p>› Middle rectal arteries </p><p> Prostate </p><p> Definition </p><p> Accessory gland of male reproduction .</p><p> Secretion of prostate , seminal vesicles & bulbourethral glands form seminal fluid. Largest male accessory gland</p><p> Located in lesser pelvis</p><p> Gross Features: </p><p> Conical shape with:</p><p>› base (sup)</p><p>› Apex (inf), </p><p> Surfaces: </p><p>› Posterior</p><p>› Anterior</p><p>› right & left inferolateral </p><p> Relations </p><p> Attached inferiorly to urinary bladder by ligaments</p><p> Posterior to pubic symphysis </p><p> Surrounds superior portion of urethra</p><p> Anterior to rectum</p><p> Anterior Surface </p><p> Ant. Surface lies at the back of retropubic space</p><p> Connected to body of pubic bone by puboprostatic ligament.</p><p> Posterior Surface: </p><p> Post.surface lies anterior to rectum</p><p> Separated from it by retrovesical fascia(Denonvillier’s fascia)</p><p> Ejaculatory duct pierces this surface</p><p> Inferolateral surfaces are related to the inferior fibres of levator ani </p><p> Base (aka:vesicular surface): superior › Attached to neck of urinary </p><p>› Prostatic urethra enters middle of base close to anterior surface</p><p>› bladder</p><p> Apex: inferior </p><p>› Prostatic urethra emerges from front of apex to become membranous urethra</p><p>› Surrounded by sphincter urethrae </p><p>› Contacts medial margins of levator ani muscles</p><p> Capsule of prostate gland </p><p> Double Capsule:</p><p> True capsule: Formed by a thin layer of connective tissue at the periphery</p><p> False Capsule: Lies outside the true capsule and is formed by condensation of the pelvic fascia</p><p> B/W these lies the prostatic plexus of veins</p><p> Lobes of the prostate gland </p><p> Anterior lobe </p><p> Connects the two lateral lobes in front of the urethra</p><p> Contains little or no glandular tissue</p><p> Rare site for adenoma</p><p> Posterior lobe </p><p> Connects the two lateral lobes behind the urethra</p><p> Lies behind median lobe</p><p> Site of origin for primary carcinoma</p><p> Adenoma never occurs here</p><p> Median lobe </p><p> Lies posterior and superior to prostatic utricle and ejaculatory ducts</p><p> May project into urinary bladder Utricle lies within lobe</p><p> Vestigial remains of uterine homolog</p><p> Sometimes called “uterus masculinis”</p><p> Common site for adenoma</p><p> LOBES </p><p> The "lobe" classification is more often used in anatomy.</p><p> Histological zones </p><p> Peripheral zone: </p><p> Upto 70% of prostate </p><p> Surrounds distal urethra</p><p> Accounts for 70-80% of prostatic cancer</p><p> Central zone: </p><p> Upto 25% of prostate</p><p> Surrounds ejaculatory duct</p><p> Accounts for 2.5% of prostate.cancers </p><p> Transition zone: </p><p> Upto 5% of prostate area</p><p> Surrounds proximal urethra</p><p> Accounts for 10-20% of prostatic cancers</p><p> Blood supply of Prostate </p><p> Arteries derived from: </p><p> a. Internal pudendal artery</p><p> b. Inferior vesical artery</p><p> c. Middle rectal artery </p><p> Veins:a. Form venous plexus b. Drain into internal iliac veins</p><p> c. Communicate with vesical & vertebral venous plexuses</p><p> Lymphatics: a. Most terminate in internal iliac & sacral nodes (unable to palpate)</p><p> b. From posterior: to external iliac nodes </p><p> Prostatic secretions </p><p> Thin, milky, alkaline (looks like skim milk)</p><p> Discharged at ejaculation</p><p> c. Make up ~ 1/3 of semen</p><p> Age changes in prostate </p><p> Grows throughout life</p><p> Responsible for BPH </p><p> Small at birth</p><p> Enlarges at puberty </p><p> 3. Maximum at about 13</p><p> 4. Progressive enlargement after 40</p><p> 5. Sometimes: undergoes atrophy</p><p> </p><p> Benign Prostatic Hyperplasia(BPH): </p><p> Affects ~90% of men >50 years of age</p><p> Characterizied by Hyperplasia of prostatic stromal and epithelial cells</p><p> Forming discrete nodules in the periurethral region of the prostate, compressing urethra and causing symptoms of:</p><p>› urinary hesitency </p><p>› frequent urination</p><p>› Dysuria › urinary retention </p><p> BPH </p><p> Diagnosis</p><p> Rectal examination</p><p> transrectal US (TRUS)</p><p> PSA level.</p><p> Drug treatment </p><p> Alpha blockers,5 alpha inhibitors.</p><p> Surgery…..TURP(Transurethral resection of prostate). Shown in the diagram.</p><p> Prostate cancer </p><p> Most common cancer in males </p><p> Metastasizes via blood (hematogenous) or lymph (lymphogenous) </p><p> Common sites: vertebrae, pelvis</p><p> a. Via venous plexus surrounding prostate </p><p> b. Bone or direct metastasis most common</p><p> PSA (Prostate Specific Antigen) </p><p> Glycoprotein, kallikrein related serine protease </p><p> Produced by secretory epithelium, drains into ductal system</p><p> cleaves and liquefies seminal coagulum formed after ejaculation</p><p> The traditional PSA threshold level of 4.0 ng/mL is considered reasonable for further evaluation of Prostate Cancer </p><p> Annual PSA testing recommended for:</p><p>› men 50+</p><p>› men 40+ at increased risk</p><p> The age to begin screening is linked to risk: › At age 50 years for average-risk men</p><p>› At age 45 years for higher-risk men (African American ethnicity or first-degree relative with prostate cancer before age 65 years)</p><p>› At age 40 years for appreciably higher-risk men (multiple family members diagnosed with prostate cancer before age 65 years)</p><p> Prostate cancer screening is not recommended in men with a life expectancy of less than 10 year</p>
Details
-
File Typepdf
-
Upload Time-
-
Content LanguagesEnglish
-
Upload UserAnonymous/Not logged-in
-
File Pages7 Page
-
File Size-